The pharmacological management of osteoporosis.

Amy E. Riek, Dwight A. Towler

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

Original languageEnglish (US)
Pages (from-to)118-123
Number of pages6
JournalMissouri Medicine
Volume108
Issue number2
StatePublished - Mar 1 2011

Fingerprint

Osteoporotic Fractures
Osteoporosis
Pharmacology
Bone Density
Adrenal Cortex Hormones
Morbidity
Drug Therapy
Mortality
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The pharmacological management of osteoporosis. / Riek, Amy E.; Towler, Dwight A.

In: Missouri Medicine, Vol. 108, No. 2, 01.03.2011, p. 118-123.

Research output: Contribution to journalReview article

Riek, Amy E. ; Towler, Dwight A. / The pharmacological management of osteoporosis. In: Missouri Medicine. 2011 ; Vol. 108, No. 2. pp. 118-123.
@article{91b2ebf373ce4c70a070a5ead8afede5,
title = "The pharmacological management of osteoporosis.",
abstract = "Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.",
author = "Riek, {Amy E.} and Towler, {Dwight A.}",
year = "2011",
month = "3",
day = "1",
language = "English (US)",
volume = "108",
pages = "118--123",
journal = "Missouri Medicine",
issn = "0026-6620",
publisher = "Missouri State Medical Association",
number = "2",

}

TY - JOUR

T1 - The pharmacological management of osteoporosis.

AU - Riek, Amy E.

AU - Towler, Dwight A.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

AB - Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=79958700007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958700007&partnerID=8YFLogxK

M3 - Review article

C2 - 21568234

AN - SCOPUS:79958700007

VL - 108

SP - 118

EP - 123

JO - Missouri Medicine

JF - Missouri Medicine

SN - 0026-6620

IS - 2

ER -